Servier

The Essentials
COMMITTED TO
THERAPEUTIC PROGRESS
TO SERVE
PATIENT NEEDS
OUR VALUES

Care

Dare to innovate

Commit to succeed

Grow by sharing
 VOCATION

We are committed to therapeutic progress to serve

patients needs

VISION
Together, we are committed to...
PLACING THE PATIENT AND INNOVATION AT THE HEART OF ALL OUR ACTIONS

• We are determined to create and provide • We intend to strengthen our leadership in

patients with innovative therapeutic solutions cardiovascular diseases and diabetes and to
that address unmet needs. take on a leading role in the fight against
cancers, immuno-inflammatory diseases and
neurodegenerative diseases.

FOSTERING INDIVIDUAL AND COLLECTIVE COMMITMENT, THE FORCE

DRIVING OUR COMPANY

• As women and men working for Servier, we • Focusing our energy, strengthening team
are proud to contribute to finding cures, spirit, promoting cross-functional
providing relief and saving lives. We act in a collaboration and being selective in our
ethical way with social responsibility, choices are essential to our global
respecting the environment in our actions. performance.
• We encourage individual fulfilment and
collective success by creating an
environment that promotes the expression of
ideas and the nurturing of talent.

GUARANTEEING OUR INDEPENDENCE AND OUR CAPACITY FOR

LONG-TERM INVESTMENT

• As an internationally recognized healthcare • We aim to be economically successful in

player, governed by a foundation, our group order to keep growing and to fulfill our
is concentrating all its resources on vocation.
therapeutic progress.

BEING A COMPANY OF GLOBAL REACH

• Based on our international success, we • We thrive on cultural diversity through the

leverage in-house skills and external sharing of knowledge and experience and
partnerships to innovate and to promote encourage employee mobility within the
worldwide access to our therapeutic company.
solutions, adapting our strategies to patient
needs.

THROUGH OUR ACTIONS WE CONTRIBUTE TO TRANSMIT TO FUTURE GENERATIONS A

WORLD THAT CAN ENSURE ACCESS TO QUALITY HEALTH CARE FOR ALL.
 Our 4 Values
to Succeed Together

Dare
to innovate
We undertake to provide
therapeutic solutions
that make a difference.
Care
We prepare for the future
Driven by a pioneering spirit,
by embracing human
We dare, we strive, we learn, and environmental
we achieve together. dimensions.
We care for the health
Dare and fulfillment of all
to innovate “Together we care”
Care is our motto.

Grow
by sharing Commit
to succeed

Grow Commit
by sharing to succeed
Every opportunity to work together
contributes to the common good. The continuous development
Whoever we are, wherever we are, of the company is vital.
We grow by working together, Whatever challenges we face, we keep
building on one another’s experiences. our promises.
Embodied by 12 commitments

• I am an entrepreneur
• I dare to be bold
• I keep an open mind

• I personify Servier social

responsibility
• I shape my own development
• I contribute to a healthy
work environment

• I build with others

• I communicate effectively
• I am a team player

• I channel my energy
• I give feedback
• I meet my commitments
 Dare to innovate
At Servier, we undertake to provide innovative
therapeutic solutions. I am an integral part of
Servier’s pioneering spirit: I dare, I strive, I learn, I
achieve as part of a team.

Commitment 1
“I am an entrepreneur”
I encourage creativity by expressing my ideas and exploring new issues. I
feel free to suggest improvement ideas and am willing to try them out.

Commitment 2
“I dare to be bold”
I draw on my skills and experience to overcome challenges that I would not
have dared tackle in the past. I explore new approaches and am fully aware
of the risk of failure. I know when to stop projects that are not producing the
expected results.

Commitment 3
“I keep an open mind”
I facilitate change and know how to adapt and challenge myself.
I build on best practices inside and outside the company.
 Care
At Servier, we prepare for the future by embracing
human and environmental dimensions. I use my skills
to improve health because I care.

Commitment 4
“I personify Servier social responsibility”
I focus on patient well-being and better healthcare. In my daily work, I
embody what Servier brings to society. I play an integral part and I am
proud to be an ambassador of the company.

Commitment 5
“I shape my own development”
I pay close attention to the Group’s needs and actively develop my own
skills and experience. I can adapt to new responsibilities and am open to
job mobility within the company.

Commitment 6
“I contribute to a healthy work environment”
I work to create a sense of trust that is vital in any healthy work
environment through a combination of performance, communication and
respect.
 Grow by sharing
Working at Servier means being a team player,
because every opportunity to work together gives us
a chance to enrich our own experience and that of
others, while benefiting the common good.

Commitment 7
“I build with others”
I provide input on all kinds of projects while taking the interests of all
everyone involved into account. I am receptive to good ideas and open
to work as part of a cross-functional team.

Commitment 8
“I communicate effectively”
I pay attention to others. I listen with empathy and am open to ideas that
differ from my own. I aim to see the big picture and make sure to find the
right words.

Commitment 9
“I am a team player”
I naturally support those around me to develop solutions together. I am
a willing contributor to projects, even outside of my own team. I respect
good collaborative practices and play an active part in team meetings.
 Commit to succeed
I contribute to continuous improvement at Servier.
Whatever challenges I face, I stay true to my
commitments.

Commitment 10
“I channel my energy”
I feel committed to Servier’s vision of the future and to my own targets. I shoul-
der my responsibilities to achieve my goals by developing my skills with the
help of colleagues.

Commitment 11
“I give feedback”
I encourage positive, constructive dialog with my manager and my colleagues
by giving regular feedback, which helps everybody to understand mutual
expectations and improve results.

Commitment 12
“I meet my commitments”
I play an active part in setting both team targets and my own goals. I know
exactly what to focus on to ensure overall improvement. I pursue continuous
improvement.
 2nd largest French
pharmaceutical company
31st worldwide

GEOGRAPHICAL 29.1%
BREAKDOWN European Union
OF REVENUE (excluding France)
(%)
12.6%
Europe
(excluding the EU)
23.6%
France

9.6% 19.4%
The Americas Asia & Oceania

5.7%
Middle East & Africa

4 16 15
Research Production International
institutes sites Centers

for Therapeutic
Research – ICTRs
 2nd largest French
pharmaceutical company

The
Servier
150
Countries
Group

€4.7 billion 66 22,500

2019/2020 Group revenue Subsidiaries Employees

Research &
Development

2,900 33 4
Employees in R&D Research projects Research institutes

25% 1,500
of sales revenue reinvested in R&D Generic drugs
each year (excluding generics) covering most diseases

Breakdown
of Revenue by
Therapeutic
Field 57% 15% 15% 6% 11%
Cardiovascular Metabolism Central Cancer Others
nervous system
(excluding generics)

*Source : IQVIA Analytics Link, September 2020

 Message from Olivier Laureau
PRESIDENT OF SERVIER

“We work every day with

passion on therapeutic
progress to save
and treat patients;
it is our vocation.”

Olivier Laureau
PRESIDENT OF SERVIER

Our company spreads across all over the world.

Governed by a non-profit foundation, it is totally
independent and committed to working, with a
long-term vision.

We are committed to innovative therapeutic solutions,

strengthening our leadership in cardiometabolic
diseases while gaining a place as a leader in the fight
against cancer, immuno-inflammatory and
neurodegenerative diseases. We are also developing
high-quality generic drugs.

We are transforming ourselves to build our future, by

strengthening the individual and collective
commitment of employees, our key asset to the
implementation of our strategic goals.

Guided by strong ethics, our collaborations with

partners, patient advocacy associations, health care
professionals, public and academic institutions,
biotech firms and start-ups help us progress.

We are a group of enthusiastic individuals with an

entrepreneurial passion to serve our vocation.
Dare to innovate

Care

Grow by sharing

Commit to succeed
INNOVATIVE
THERAPEUTIC SOLUTIONS WORLDWIDE

100 eighth worldwide in oral treatments for

type 2 diabetes.
sustainability,
– unity and harmony,
million patients AN EXPANDING ONCOLOGY – being a group of people and not of
treated daily with PORTFOLIO capital.
Servier drugs Servier has made cancer a top This structure allows the Group’s
research priority, supported by ample Vocation to express itself fully: to be
resources. committed to therapeutic progress.
We are an independent Group
To meet the growing needs of The general principle of this unique
governed by a non-profit foundation:
patients, we are expanding our structure is to dissociate the power
Servier International Research
portfolio of cancer treatments, which (i.e. administration and control) from
Foundation (Fondation Internationale
currently includes five drugs for the ownership of capital (i.e. the
de Recherche Servier.
colorectal, stomach, and pancreatic Group’s assets).
cancers, as well as leukemia.
We draw on a historical global – The power is ensured by a
presence to provide health care governance foundation named
GETTING TO HEALTH CARE 3.0 ‘FIRS’ (Fondation Internationale
professionals and patients with a
broad range of drugs and treatments. The digital revolution is shaking up de Recherche Servier) without
The Group’s range covers five areas health care: big data, connectivity, capital and not for profit; This
and mobile applications, etc., includes the power to appoint or
of expertise: cardiology, diabetes,
the advances are striking and are dismiss Group leaders;
cancer, neuropsychiatry, and chronic
changing the roles of patients and – The capital of the Group is held,
venous diseases.
practitioners. With our e-health in part, by French non-profit
business – WeHealth by Servier – we associations and is self-regulated
LEADER IN CARDIOLOGY are building this connected health for the remaining parts (legal
We are second in Europe and fifth care universe to better accompany structure enabling a company to
worldwide in cardiology, third in patients in their treatment plans. hold its own capital);
Europe and fifth worldwide in arterial – The holding company of the
hypertension. Servier is the only THE LEGAL STRUCTURE OF THE Group (Servier SAS) is therefore
pharmaceutical company to offer a SERVIER GROUP, AN not held by any individual. It
selection of 16 available drugs for INTERNATIONAL reinvests all its profits into
doctors and patients to treat PHARMACEUTICAL COMPANY, therapeutic progress and
cardiovascular diseases. AIMS FOR: company growth.
Additionally in diabetology, we rank independence, stability and

An independent, Global pharmaceutical group

governed by a non-profit foundation
Figures as of September 30, 2020

31st largest pharmaceutical Group worldwide* 100 million patients� treated

2nd largest pharmaceutical Group in France each day in 150 countries�
by Group medicines

Leader in cardiology
22,500 employees 5th leading pharmaceutical group in
cardiology worldwide*

Ambition to become
€ €4.7 billion Group revenue
- Brand-name medicines: €3.3 billion
- Generic medicines: €1.4 billion
�a renowned and innovative
player in oncology

23% of Group brand-name

€626 million EBITDA
revenue invested in R&D in 2019/2020

*Source : IQVIA Analytics Link, September 2020 EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization
LOCAL PRESENCE
A BROAD RANGE OF GENERIC DRUGS,
QUALITY ALTERNATIVES FOR PATIENTS
development of the Group and its effective response to the challenge of
31% ambition to make health care
accessible to as many people as
controlling health care costs to give
more patients access to innovative
of Group revenue possible. treatments.
in 2018
HIGH-QUALITY PRODUCTION

+ 1,500
The subsidiaries of the Group
specialized in generics offer a range
of nearly 1,500 drugs for most
OUR FOUR
Generic drugs GENERICS SUBSIDIARIES
diseases and conditions. They employ
marketed in 60 countries
almost 4,500 people.
The majority of our generic drugs are
BIOGARAN
Through its four specialized manufactured in Europe in the
(France)
subsidiaries, the Group offers a broad Group’s plants and those of our
partners which meet our quality •
range of high-quality generic drugs.
standards. EGIS
This steadily evolving business
(Eastern Europe)
increases the number of treatment
options for patients. •
DIVERSIFICATION IN BIOSIMILARS
PHARLAB
Through its specialized subsidiaries, (Brazil)
A GROWING BUSINESS AREA the Group is increasingly involved in •
The global offer of Servier, with biosimilars, drugs that are like SWIPHA
generics, brand-name drugs, and well-known biological medicines in (Nigeria)
e-health, distinguishes it from most areas such as oncology and
large pharmaceutical groups. rheumatology. Biosimilars are an
Generics are part of the dynamic

THE FUTURE SERVIER

PARIS - SACLAY
RESEARCH INSTITUTE

Over 600 researchers in the Group will

be brought together at the heart of the
scientific innovation division
of Paris-Saclay, in facilities that will be
equipped with cutting-edge technologies
and infrastructure.
FOCUSED R&D FOR A TARGETED INNOVATION
DYNAMIC

FIVE
THERAPEUTIC
AREAS
140
8.24 PM
9 - 17
mg/dl

Cardiovascular Diabetes
Diseases

Immune Cancer
Inflammatory Diseases

Neuropsychiatric Diseases

Within its five therapeutic areas, specializes in a limited number of (programmed death of tumor cells),
Servier has chosen to focus its diseases, such as heart failure, and immuno-oncology.
research and development on a autism and leukemia.
limited number of diseases for PARTNERSHIPS TO BOOST
which the medical needs are ONCOLOGY: A KEY PRIORITY INNOVATION
substantial.
Combatting cancer is one of To accelerate research and develop
Servier’s research priorities. The future treatments, Servier Group has
A CONTINUOUS INNOVATION share of oncology R&D investment instituted a policy of open innovation
APPROACH grew from 14% in 2015 to 37% in through dynamic partnerships.
In order to address unmet medical 2018 and accounted for 50% by So far it has established about fifty
needs, Servier is developing 2020. alliances with partners including not
33 research programs and 33 The Group is exploring two only laboratories, but also innovative
prospective drugs. avenues: therapies focused on biotech firms, academia, and
Within each therapeutic area, it reestablishing apoptosis business incubators
REINVENTING THE WAY WE WORK
QUALITY PRODUCTION TO ENSURE THE SAFETY
OF PATIENTS
All Servier’s production sites brand-name drugs and generics alike,

16 worldwide respect the quality and

safety standards in force to produce
notably through online sales. To fight
against this public health menace,
production sites therapeutic solutions of equivalent Servier has set up an internal program
in 11 countries efficacy. to establish serialization, aggregation,
and unit traceability for boxes of drugs
and is working with customs and
98% QUALITY CONTROL TO
GUARANTEE PATIENTS’ SAFETY
health authorities across the globe
and other laboratories.
of drug substances What is the strength of Servier Group?
manufactured in-house Perfect control of all the stages in the
(excluding generics) lifecycle of a drug, from research to INVESTING IN BIOMEDICINES
distribution. To guarantee the quality Biomedicines obtained not from

2020 of our drugs they are produced at the

sixteen production sites of the Group,
chemistry, but from living organisms
or their cellular components are a
start of the production which meet the regulatory standards great therapeutic advance, especially
of biomedicines in France and integrate R&D activities. for treating cancers. That is why
Servier is investing in a new
production unit, called BIO-S, at the
COMBATTING COUNTERFEIT Gidy site in France. The first
DRUGS biomedicines, to be used in clinical
Counterfeiting of drugs is a growing trials, were produced in 2020.
phenomenon that concerns

SERVIER CDMO: INDUSTRIAL TOOL OPEN TO THIRD PARTIES

Through its Contract Development and Manufacturing Organization (CDMO) offer, Servier gives
third-party companies access to its equipment and the expertise of its teams for drug development
and manufacturing.
 FOR PATIENTS, WITH PATIENTS

Servier works for and with patients, At Servier, we put patients first. They patients and their caregivers go
providing medical professionals with are at the heart of each of our through during treatment. In some of
innovative and effective drugs. Better activities. We believe that the best way our clinical studies, for example in
informed, more involved and to meet their current and future needs oncology, we involve patients and
connected, patients are increasingly is to work together. associations in drafting informative
recognized as participants in their own All of our considerations, decisions, documents or choosing and revising
health care and partners for medical and actions-from basic research to quality- of-life questionnaires. We are
progress (clinical trials, access to getting a medicine to market-are co-creating solutions to help them, and
innovation, support). We are governed by this central position of their families cope better with their
committed to co-creating therapeutic patients. diseases.
solutions with them.
Our commitment will take the form of
two-way dialogues with patient FACILITATING THE PATIENT
PATIENTS ARE AT THE HEART associations to forge real partnerships TREATMENT PLAN
OF OUR WORK and provide medium-term solutions in We are developing therapeutic
line with their expectations. solutions “beyond the pill” to ease the
care cycle for patients and their loved
In this regard, our Group will
ones.
co-construct clinical trials for
therapeutic solutions with patient For this we have deployed innovative
associations. Furthermore, we will tools within the Group, whether
make sure that patients wishing to applications, web pages on our
participate have clear and products, or dedicated sites.
understandable information.
Our guiding principles for working with WORKING FOR AND WITH
patients are based on four PATIENTS
fundamental points: transparency, In addition, we created a new
independence, listening, and respect. department dedicated to patients, led

130
by our Chief Patient Officer, whose
mission is to make our staff
BETTER UNDERSTANDING
increasingly patient-focused, assuring
digital tools PATIENTS AND THEIR LOVED
collaboration with patients and patient
developed to facilitate ONES
associations.
the pathway of We are developing partnerships with
patient associations and health care
patients and their
players to better understand what
close family members

PARTNERSHIPS TO IMPROVE PATIENT ENGAGEMENT

Servier has joined PARADIGM,
a public-private partnership, and Patient-Focused Medicines Development (PFMD),
an independent platform, to increase the engagement of patients throughout
the drug development cycle.
 Children always speak the truth.
It’s time to listen.

“Grandpa, I can’t even

pronounce ‘hypertension,’
but I do know you need to
get your blood pressure
checked”

Hypertension increases the risk of stroke and cardiovascular disease, yet 1 in 2 people do not know they have it1
Make sure your parents and loved ones get their blood pressure checked today.

1. Chow CK, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013;310:959-68.

GOT
BLURRED
VISION?
Blurred vision
is one of the symptoms
of type 2 diabetes

TALK TO YOUR DOCTOR

ABOUT TESTING

I A B E T ES
W FORD
#ACTNO
INCREASED EXTREME BLURRED
THIRST FATIGUE VISION
TYPE 2 DIABETES IS A CHRONIC DISEASE THAT EVOLVES SILENTLY
However, certain symptoms such as increased thirst (usually linked to dry mouth and frequent urination), extreme fatigue and blurred vision may signal you have the disease.
1 in 2 people don’t know they have diabetes until they develop complications.
Be part of those who know! THE SOONER YOU CONTROL IT, THE BETTER OFF YOU WILL BE.

Issued in public interest

Serdia Pharmaceuticals (India) Pvt. Ltd.
1703, 17th Floor, Parinee Crescenzo, B Wing, G Block, C38 & 39, Behind MCA,
Bandra Kurla Complex, Bandra East, Mumbai 400051 - INDIA Disclaimer: The person shown in this document are being
Under Licence from : Les Laboratoires Servier, France used for illustrative purposes only and are professional models
Visit us at : [Link]
 RESPONSIBILITY AND COMPLIANCE: ETHICS AT
THE HEART OF OUR ACTIVITIES
Servier has a responsibility to society A CULTURE OF RESPONSIBILITY environmental model, creating value
to guarantee the integrity of the actions Servier ensures that all its employees and leveraging performance for all
of its staff and preserve our common and partners respect the regulations internal and external stakeholders.
future. and ethical standards of the Group
wherever it operates. As an TAKING CARE OF
ETHICS OF THE GROUP independent pharmaceutical THE MOST VULNERABLE
Servier’s values, best practices, and company, we are particularly aware of Mécénat Servier backs general
ethical standards should assure that our responsibility toward patients, interest initiatives in France and
every employee acts responsibly health care professionals, and abroad, demonstrating the Group’s
toward his/her fellow peer and society employees. desire to strengthen its philanthropic
in all the countries where the Group is commitments. Our endowment fund
active. This is in line with the Group’s AN INCLUSIVE AND currently supports sixteen
Ethics Charter and Code of Conduct, PARTICIPATIVE CSR APPROACH associations, including Helen Keller
which are two-fold with two Servier’s CSR policy involves all of the International, Planète Urgence, and
dimensions – our policies on Group’s business lines and the Cardiopediatric Cuomo Center in
compliance and our Corporate Social subsidiaries and promotes a Dakar.
Responsibility (CSR). sustainable social, economic, and

CORPORATE SOCIAL RESPONSIBILITY

FOUR COMMITMENT AREAS

COMMITTED TO CARING
HEALTH CARE ABOUT PEOPLE

FOCUSED ON OUR AIMING FOR A

BUSINESS PRACTICES POSITIVE FOOTPRINT

3 ACTION AREAS

LIVING
TOGETHER
A STRONG INTERNATIONAL FOOTPRINT

Servier has steadily developed its R&D and production, Servier Group

2018 presence in both mature and emerging

countries to respond to the needs of
has a truly international focus. It
continues to invest globally, as
year of Servier patients in the territories where we demonstrated by the recent opening of
commercial establishment operate. subsidiaries in Peru, Nigeria and the
in United States United States.
A DIFFERENTIATED

66
GEOGRAPHICAL FOOTPRINT SERVIER IN THE UNITED STATES
Servier is present in 150 countries. The acquisition of Shire’s Oncology
subsidiaries This strategy of local representation branch in 2018 marks the Group’s
allows us to respond appropriately to commercial establishment in the
patients based on the special United States, the world’s leading
characteristics of each country. The pharmaceutical market.
Present in
Group has 66 subsidiaries,
150 16 production sites in 11 countries, 15
International Centers for Therapeutic
This commercial presence supports
partnerships developed by Servier
countries Research and is currently focused on over many years with private and
developing an international research public players, including Harvard, MIT,
network across global innovation and the University of San Francisco.
centers. Servier’s future in the United States
lies on the development of commercial
INTERNATIONALLY DRIVEN activities and finding opportunities for
GROWTH R&D, as well as business
development and licensing.
While firmly anchored in France for

PASSIONATE
The Group’s dynamic is driven by the WORKING DIFFERENTLY
commitment of each employee. To Working at Servier means
ensure employee development and experimenting with innovative and
AND COMMITTED fulfillment, Servier strives to create a
serene and stimulating work
flexible ways of working to strike an
excellent work and personal life

TEAMS
environment, in complete safety. balance:
part-time work, working remotely,
ENTREPRENEURIAL SPIRIT AND workspaces designed to be conducive
PASSION FOR INNOVATION to idea generation and sharing, as
Working at Servier means joining an well as skills-based volunteering and

22,500 independent international Group,

equipped to achieve its long-term
solidarity leave.

employees in vision and sharing the passion to CUSTOMIZED CAREER PATHS

150 countries undertake and innovate with teams
In all countries where it is present,
committed to therapeutic progress to
Servier offers employees the
serve patient needs.

101
opportunity to build rich and varied
careers. Diversity and global mobility
LONG-TERM RELATIONSHIP are promoted no matter the
professions professional area, including research
Working at Servier also means
experiencing a long-term relationship and development, production,
based on trust and goodwill, starting promotion and cross-function roles.
with a tailored integration path for new
hires.
 SERVIER INDIA
Serdia Pharmaceuticals (India) Pvt. Ltd.

We are committed to therapeutic progress

to serve patient needs
 SERVIER
Milestones

First production unit International development Commercial operations Creation of Biogaran Mr. Olivier LAUREAU SERDIA Pharmaceuticals
constructed in begins with the opening of begin in INDIA on 30th July is appointed President crosses a headcount of
Fleury-les-Aubrais (France). the first subsidiary in London with the formation of of the SERVIER Group 500 employees.
Growth gathers pace due to (England) SERDIA Pharmaceuticals and the SERVIER SERDIA’s Head Office
focus on research (India) Pvt. Ltd International Research moves to BKC,
Foundation (FIRS) a commercial hub in
Mumbai (India)

First Stone laid at SERVIER

Research Institute
Paris - Saclay (France).

First bioproduction
batches in Gidy (France)

Dr. Jacques SERVIER

creates a pharmaceutical The first external growth Relocation of SERVIER
company in Orleans (France). Gidy ‘factory village’ built operation with the Head Office to
A year later, the company in the Loiret department of acquisition of a 51% Suresnes (France). SERVIER opens its first
launches its first two drugs Opening of SERVIER France, becoming the shareholding in the SERVIER surpasses 20,000 office in USA, with the
(an antihypertensive and Research Center in social showcase of the Hungarian company, employees, including acquisition of SHIRE’s
an antidiabetic) Suresnes (France) SERVIER Group Egis Pharmaceuticals nearly 3000 in research Oncology business
 Servier in India

5 Zones 60 Headquarters

North
Amritsar
Jalandhar
Chandigarh
Dehradun
East
Ludhiana
Muzaffarapur
Ambal Meerut
Delhi Moradabad
Dibrugarh
Ghaziabad
Agra
Guwahati
Jodhpur Lucknow
Jaipur Kanpur
Allahabad Patna Siliguri
Udaipur
Varanasi Agartala
Ahmedabad
Bhopal
Baroda Howrah
Indore Ranchi
Rajkot Jabalpur
Kolkata
Surat Raipur Cuttack
Nasik Nagpur
Aurangabad
Bhubaneswar

West
Pune
Mumbai
HO

Kolhapur
Hyderabad Central
Vishakhapatnam

Goa Vijayawada

Guntur
Bangalore
Mangalore Chennai

Calicut Coimbatore Pondicherry

Trissur Trichy
Cochin Madurai
South
Trivandrum Tirunelveli
About Servier India
Serdia Pharmaceuticals (India) Pvt. fraternity for its original products, happy and comfortable work
Ltd. has been in existence in India strong scientific base and ethical environment where colleagues are
since 1986. promotion. helpful, motivating and supportive to
The Mumbai Head Office houses each other.
India has always been a very
important country for the SERVIER various departments, each As a whole, this fosters an
GROUP because of its unique department is unique in its own environment in which diverse
geographical location, its size and its functionalities. We have departments individuals are all connected by their
significantly high population. Serdia like Product Promotion, Learning & contributions towards a common goal.
currently employs more than 550 Development, R&D Department, We thrive on cultural diversity through
people – of which almost 450 Legal Department, Sales Department, the sharing of knowledge and
comprise highly competent field force Human Resources Department. All experience and encourage employee
professionals with very sound the departments work in oneness or mobility within the company.
scientific knowledge. The company is togetherness, and a harmonious
well-respected in the medical relationship with colleagues shapes a

LIFE IN SERDIA
Our culture is very unique and synergistic: it builds trust and confidence amongst employees, helping
them to develop as regards commitment, integrity and discipline towards their job. It allows people to
explore their creativity and thus to realize their latent talents, thereby inspiring them to go beyond their
normal call of duty.
The work environment at Serdia is highly professional and yet employees bond as a family, celebrating
customs and festivals in a true spirit of togetherness. Team Serdia invokes the spirit of oneness and
close bonding among all Serdians in order to achieve superior performance year after year. Various
team-building activities are held regularly in order to develop this spirit in every Serdian.
Serdia celebrates various occasions with all Serdians and their families. The ideology behind this, is to
ensure that all employees sense the comfort of being at home, and moreover being a part of the Serdia
family, thus enjoying the time spent at work.

Servier India Servier India

SERDIA, a subsidiary of a research Distribution of % revenue as of

based French multinational – the September 30, 2020
Servier Research Group.

● Manufactures and Distributes ● Diabetology 36% (₹108 Cr.)

original research in quality products
of Servier ● Cardiology 25% (₹ 77 Cr.)
● Is well respected in the medical
fraternity for scientific and ethical ● Hypertension 25% (₹ 77 Cr.)
promotion
● Venous disease 11% (₹ 32 Cr.)
● Is a main player in the fields of
cardiology, metabolism & venous ● Others 3% (₹10 Cr.)
disease.
● Serdia – a fast growing company
Celebrations
 SERVIER INDIA
DURING COVID-19

VISIT US:
HTTPS://[Link]/SERVIERINDIA
HTTPS://[Link]/COMPANY/SERVIERINDIA/
 COVID 19 PANDEMIC
During the Covid 19 pandemic, Serdia undertook to
support all its employees and ensure their safety
and wellbeing.

All tools and facilities were provided to make "work

from home" as comfortable as possibel for all
employees.

A "Key to Unlock the Lockdown Safety Guidelines"

video was circulated to sensitise all about the
precautions and safety measures to be follwed at
all times

The organisation supported a good work-life

balance by encouraging all employees to take
leave periodically so that they could spend time
with their loved ones, and return feeling
rejuvenated.

EMPLOYEE CONNECT
Serdia believes in keeping a close connect with employees and their families. Through "RiSerdia", an employee
engagement platform, several activities are conducted for employees & families to
connect, encouraging them to take up extracurricular pursuits. and to showcase their
latent talents.
Following are some of the activities conducted :
MoM&DaD@Home:
offspring of employees were invited to send their perception and depiction - through
drawing, painting, essay, poetry - of having their parent at home during the pandemic
Home Office Photo Contest:
Employees were invited to share photos of their working at home environs and
experience.
One-Minute Games
These fun games encompassing trivia and quiz games were conducted for smaller
groups of employees along with their families.
Serdia’s Got Talent
RiSerdia invited Serdians to exhibit their talents in singing, dancing, mimicry, and
stand-up comedy. The overwhelming responses was heartwarming, both in solo and
group categories. Shortlisted acts were showcased
during the Serdia’s Got Talent show which was
broadcast at the gala closing of the Serdia National
Sales Conference. ®

Christmas Carol singing program

Every year, the Serdia Christmas Carols choir
puts up an afternoon of carol singing rendition at
the head office. This is always a joyful event full
of fun and excitement, celebrating the holly jolly
Christmas spirt. During the 2020 pandemic, this
program was conducted as an online event, with
participation from employees and a few kids, from
the head office and the field.
NURTURING
ENGAGEMENT
National Sales Conference

Since SERDIA’s inception, the annual National Sales

Conference (NSC) has always been one of the biggest
events of the year. The NSC usually is a 5-day event,
hosted at a domestic or international location, with
most employees in attendance.

Being a mega event, it involves a massive

collaborative effort of employees from all departments,
with meticulous planning to ensure a smooth
implementation of all aspects of the event – travel,
accommodation, logistics, ground transportation,
meals, multiple meeting rooms, branding,
team-building activities and recreation.

The main aim of the NSC is to analyse the sales performance of the year gone by, to set goals for the upcoming
year and impart training on ways to achieve these goals. Alongside the business agenda, Serdia does not miss
the opportunity to include some team-building and recreational activities.

The NSC is also a good platform to celebrate successes

and to honour the dedication and long-service of its
employees. During the Performance Awards
ceremony at the NSC, all the top performers of that
year are called up on stage and presented with
medals and trophies by the top leadership team, for
various categories of achievements. The most sought
after award is the SERDIA Rolling Trophy which is
awarded to the best-performing region This public
recognition bestowed upon high-performing
employees & teams, is a great source of inspiration
propelling all teams to aspire for these coveted
accolades.

Another public awards ceremony is the presentation of Long Service Awards during the NSC. SERDIA celebrates
long term associations with its employees in an inspiring fashion by publicly acknowledging tenure, thus reflecting
its values of going beyond an employee-employer relationship and making the employee feel like a part of the
SERDIA family. The Long Service Awards are presented
in a glittering ceremony, during which each recipient
gets a medal and certificate, which are presented to
employees who have completed a tenure of 5+ years,
in increments of every 5 years and beyond (example,
5, 10, 15, 20, 25, 30, 35 years).

The NSC concludes with a gala dinner, where

Serdians let their hair down and celebrate the
successful conclusion of the event with free-flowing
food and drink, accompanied by song, dance and
revelry.

Being the most-looked forward to event of the year,

even during the 2020 pandemic, SERDIA ensured to conduct this event digitally, while including all elements of
a normal NSC. In fact, the gala closing event was a show-stopper broadcasting the Serdia’s Got Talent show,
which showcase the latent talents Serdians and was a source of great entertainment for all fellow Serdians
watching.
 Chai pe Charcha

Chai pe Charcha is an initiative launched recently as

part of our ongoing thrust to widen the scope of
interactions between management and employees, at
all levels, be it rank or file. We hope to create more
platforms and opportunities for employees to opine,
drop feedbacks or discuss what they have in mind. We
practice the open office culture, so as to allow
uninhibited dialogues. With every passing day, we
strive to communicate better with our employees and
continue to be more and more open to dialogues in all
forms.
 SERVIER INDIA

99 463
Employees Employees
in Head Office in Field Force

₹ 377Cr. 15%
Total Turnover Average Growth Rate
(2020-21) (last 3 years)
STRONG
PRODUCT PORTFOLIO

CARDIOVASCULAR
DISEASES

perindopril erbumine tablets B.P. perindopril erbumine and amlodipine besilate tablets

perindopril erbumine and indapamide tablets perindopril erbumine and indapamide tablets
Scored tablet

indapamide sustained release tablets I.P.

Indapamide sustained release and amlodipine besilate tablets

trimetazidine modified release tablets trimetazidine hydrochloride extended release capsules Coralan
ivabradine hydrochloride tablets
®

1 tablet twice daily

DIABETES

5.8
gliclazide and metformin hydrochloride extended release tablets gliclazide extended release tablets

VENOUS
DISEASE

micronized purified flavonoid fraction tablets

500mg micronized purified flavonoid fraction tablets
1000mg
Corporate Social Responsibility
Corporate Social Responsibility
Servier has always been involved in philanthropic initiatives in France and other countries of operation. The Group’s
involvement in Corporate Social Responsibility (CSR) actions worldwide are directly inscribed in its vocation. This mission to
care through our actions was materialized by the launch of the Mécénat Servier Charity Fund in November 2016. The Fund’s
goal is to promote and take part in community-interest activities or projects, both directly and indirectly, in France and around
the world, for actions that align with our Group’s values - Commit to Succeed, Dare to Innovate, Grow by Sharing and Care.

Mécénat Servier
Mécénat Servier is particularly committed to supporting projects and actions in
the areas of Healthcare, Education, Living Together, Culture. This spirit of social
responsibility is very much reflected in the day-to-day life and work of
SERDIANS. In 2020, Mécénat Servier had launched the Solidarity Leave -
Local to Local pilot project for SERDIA in India, in partnership with Planète
Urgence, an NGO dedicated to international solidarity, sustainable local
development and environmental conservation. Their Mission is to allow
everyone to be active in the
development of their community through their Volunteer and Environment &
Development Programs, by participating in a hands-on missionary project.
At Serdia, one employee was shortlisted in order to pursue a project site that was
based in Pondicherry. The Mission in “People Social Development Foundation”,
was “Training in Microsoft Excel and Word for women’s leaders groups”
At Serdia, we endeavour to walk in the footsteps of Servier and create meaningful
engagement opportunities for our employees through our CSR initiatives, while
creating a positive footprint for the NGOs we support. Serdia supports several CSR
activities which make a difference to the lives of the deprived sections of society.

Serdia has been consistently supporting the following NGOs – charitable contributions made by Serdia under the CSR
Activity.

Reality Gives
REALITY GIVES, an NGO working
towards providing quality education in
English medium for under-privileged
children in Dharavi. Apart from monetary
assistance, Serdia has organised field
visits for its employees to the Royal City
School in Dharavi, allowing meaningful
interactions with the students and faculty.
In December 2019, a group of 40 students
from the Royal City School, along with a
few faculty, were invited to visit the Serdia
head office in BKC. This was a first-ever
kind of thrilling experience for the school
kids to visit not only the BKC business
district, but also a very state-of-the-art
MNC office, where they were given a
simplistic tour of the functioning of all
departments. For Serdians, it was
immensely satisfying to have the little kids
over and watch them display their
knowledge and talents through their
innovative skits.
 Gift
GIFT (Girls Inspired For Tomorrow), which
works for the education of underprivileged
girls while providing them with lunch and
shelter during the day. We, at Serdia,
believe in empowering the girl child, and
ensuring that all initiatives are directed
towards a unifying goal of giving every
child a dignified life by providing financial
support towards their betterment and a
brighter tomorrow.

Smt. Kamala Mehta Dadar

School for Blind

Serdia also undertakes charitable

endeavours at Smt. Kamala Mehta
Dadar School for Blind, which
imparts academic education from
pre-school to S.S.C. & College-
going students along with hostel
facility to visually impaired girls
coming from varied socio economic
background belonging to any caste,
creed & religion.

Diabetes International Research Education and

Charitable Trust (DIRECT)
Rendering medical camps to offer free service to the economically weaker section of the population in and around Chennai.

Komala Ramanujam Trust

Promote health education programme for non-communicable diseases among the school children and provide
recommendations to school teachers (tool kit) to inculcate improved lifestyle practices to students.
 During the 2020 pandemic, Serdia partnered with the
Americares Foundation, to provide PPEs kits to frontline
health workers in various government institutions in
Maharashtra.
Donation to Americares India Foundation was used for
providing the protective equipment for the health workers and
support MCGM during COVID 19 pandemic.

French Solidarity Mission

While India is facing a second wave

of the deadliest Covid 19 pandemic,
Serdia Pharmaceuticlas, contributed
to a French Solidarity mission which
was set up to raise funds to relieve
the country’s patients suffering from
a lack of oxygen.
These funds have been used to
purchase oxygen plants in France
which were imported and installed in
few hospitals across India.

ESIC Medical College

PGIMSR & Model Hospital -
Bangalore
Serdia Pharmaceuticlas, played a vital rôle
in providing 200 N95 Masks and 50 PPE
towards Covid 19 preparendess at ESIC
Medical College PGIMSR & Model
Hospital - Bangalore.
In the year 2021, Serdia supported the following 2 NGOs committed to the causes of education
disability and child labour.

Quality Education
Support Trust (QUEST)
Quality Education Support Trust
(QUEST), which pursues quality
related issues in Early Childhood
Education, elementary education and
teacher professional development,
primarily through action-research in
pedagogy. QUEST has designed
various programs for tribal and rural
schools, teachers and teacher
educators.

Civilian Welfare Foundation

Civilian Welfare Foundation, Poddar Park,
which supports disability rights, people with
disabilities, transgenders and child labourers in
Kolkata.
Let’s stay connected
discover our website
[Link]

[Link]

[Link]

[Link]

SERVIER INDIA
Serdia Pharmaceuticals (INDIA) Pvt. Ltd.
1703, 17th Floor, Parinee Crescenzo, ‘B’ Wing,
Plot. Nos. C38 & 39, “G” Block, Behind MCA, Bandra Kurla Complex,
Bandra (East), Mumbai – 400051, Maharashtra, INDIA.